跳至主要内容
临床试验/NCT04035551
NCT04035551Unknown不适用

Health Evaluation And Learning for Total Parenteral Nutrition (TPN) at Home (HEALTH)

Coram Clinical Trials1 个研究点 分布在 1 个国家目标入组 1,700 人开始时间: 2019年6月17日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
1,700
试验地点
1
主要终点
Efficacy of Home Parenteral Nutrition defined as the percentage of patients reaching their PN therapy goals

研究概览

简要总结

The HEALTH Registry is a prospective, observational, non-interventional registry study of patients receiving home parenteral nutrition therapy in the US for a variety of indications.

详细描述

The objective of the HEALTH Patient Registry is to establish and track therapy utilization and outcomes of patients receiving home parenteral nutrition therapy. Data collected will include information on patient safety, clinical outcomes, resource utilization and health-related quality of life (QOL). The goals of this Registry include:

  • To better understand the patients and populations requiring HPN in the U.S.
  • To measure clinical outcomes associated with HPN
  • To identify areas for focused quality improvement interventions
  • To provide opportunity for resource allocation identification and improvement

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patient of any age, gender, and indication referred to Coram/CVS Specialty Infusion Services to receive HPN in an alternate site of care, such as the home or infusion suite
  • Patient must be managed by Coram/CVS Specialty Infusion Services
  • The patient or the patient's caregiver must be willing to receive care and comply with the teaching and training necessary to administer treatment

排除标准

  • Patient is unable to start, or stops receiving HPN
  • Patient is NOT managed by Coram/CVS Specialty Infusion Services
  • A patient and/or a patient's insurance will not cover cost of HPN therapy with Coram/CVS, or a patient elects not to start treatment

结局指标

主要结局

Efficacy of Home Parenteral Nutrition defined as the percentage of patients reaching their PN therapy goals

时间窗: through study completion, an average of 3 years

The therapy goals (i.e. weight gain, weight loss, weight maintenance, resolution of GI issue, etc). will be recorded at study start. Percentage of patients reaching their designated therapy goal will be recorded (presented as a single percentage of patients that successful reached any therapy goal)

Change in Quality of Life over time: The Short Form (36)

时间窗: At baseline and every 6 months during therapy through study completion, up to 3 years

To examine the effect of HPN support on quality of life (functional health and well-being) as measured by The Short Form (36) Health Survey (SF-36v2). Physical component summary (PCS) and mental component summary (MCS) scores on a scale of 0 to 100 with higher scores reflecting better outcomes will be utilized.

次要结局

  • Mortality rate(through study completion, an average of 3 years)
  • Catheter-related infections(through study completion, an average of 3 years)
  • Number of hospital readmissions and ER visits(through study completion, an average of 3 years)

研究者

发起方
Coram Clinical Trials
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验